# Bioreliance Corporation – FDA Inspection, Nov 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/7941bc6b-db19-4266-b05d-af8a19fbde51
Source feed: FDA_Inspections

> FDA inspection 1254934 of Bioreliance Corporation, November 22, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1254934
- Company Name: Bioreliance Corporation
- Inspection Date: 2024-11-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Vaccine, Allergenic, and Live Biotherapeutic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Baltimore District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1295306 - 2026-01-29](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/e199758b-3727-437f-82a7-ea444bde9780)
- [FDA Inspection 1215040 - 2023-08-04](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/89149f6b-0201-4f3c-9500-60de669dfba4)
- [FDA Inspection 1099981 - 2019-08-08](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/7e151514-be3f-4b8f-ba64-e4ad411f7cc0)
- [FDA Inspection 1059115 - 2018-07-13](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/ba69306a-6c03-404f-b4e3-7b18e0e140f0)
- FDA Inspection 983525 - 2016-01-11

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)

Company: https://www.keypedia.com/companies/bioreliance-corporation/08d3dc20-6c7e-4f04-bb98-bbc868e70000

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa
